SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000078003-19-000079
Filing Date
2019-10-29
Accepted
2019-10-29 08:54:32
Documents
18
Period of Report
2019-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pfe-10292019x8kcoverpa.htm   iXBRL 8-K 61218
2 EXHIBIT 99 PFIZER INC. PRESS RELEASE pfe-10292019xex99.htm EX-99 2771422
8 oldpfelogowhite.jpg GRAPHIC 95575
9 pfizerlogo2019.jpg GRAPHIC 15668
10 upjohnlogo.jpg GRAPHIC 230605
  Complete submission text file 0000078003-19-000079.txt   3625133

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20191029.xsd EX-101.SCH 5281
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20191029_cal.xml EX-101.CAL 615
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20191029_def.xml EX-101.DEF 16030
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20191029_lab.xml EX-101.LAB 35770
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20191029_pre.xml EX-101.PRE 18056
13 EXTRACTED XBRL INSTANCE DOCUMENT pfe-10292019x8kcoverpa_htm.xml XML 9081
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 191174593
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences